Targeted therapy in Spain typically costs from $15,000 to $25,000 per session or dose. Final expenses depend on the specific cancer type, drug concentration, and necessary genetic testing. In the US, similar treatments cost $40,000 on average, while patients in Spain save approximately 50%. Packages often include cancer marker blood tests and specialized oncologist consultations.
- Lutetium-177 therapy: $12,000 to $18,000 for advanced prostate cancer or neuroendocrine tumors.
- Actinium-225 therapy: $45,000 to $80,000 for targeted alpha-particle treatment of resistant cancers.
- Advanced diagnostics: PET/CT scans and biopsies typically add 10-15% to the initial treatment budget.
- City variations: Treatment in major hubs like Barcelona and Madrid serves the highest patient volumes.
Bookimed Expert Insight: Choosing Spanish centers provides access to elite US-standard protocols at a lower cost. For example, Centro Médico Teknon follows Memorial Sloan Kettering Cancer Center guidelines. Packages there start around $14,550 per dose. Research-heavy institutions like Clinica Universidad de Navarra offer specialized care for rare conditions. They maintain a 74% cure rate for bone sarcoma using these advanced methods.